Stem Cell Therapy Shows 94% Reduction in Osteoporosis Fractures in First Human Trial
Source Summary
A first-in-human stem cell trial demonstrated a 94% reduction in osteoporosis-related fractures. Osteoporosis, which weakens bones by reducing mineral density and mass, affects an estimated 75 million people across Europe, the USA, and Japan. The disease causes approximately one bone fracture per minute globally in women over 50.
Why it matters
Osteoporosis affects 75 million people across major developed regions and causes significant morbidity; a 94% reduction in fractures in a first-in-human trial represents a potentially transformative therapeutic advance for this widespread disease.
